Abstract
The uniqueness of human sagittal spinal alignment, and its link to the distinct phenomenon
of idiopathic scoliosis are studied in this thesis, with an emphasis on contemporary
imaging techniques. Spinal ultrasound is introduced in this thesis as a radiation-free
alternative to X-rays, thereafter verified and implemented in standard scoliosis care.
... read more
Furthermore, it was discovered that already discrete differences are present in the
straight spines of healthy children, that may play a role in the development of scoliosis
later in life: e.g. intervertebral disc slenderness, observed to be especially present in girls
in their mid-thoracic area during early adolescence. In scoliosis of different etiologies it
was demonstrated that axial rotation into the curve convexity combined with lordosis,
i.e. anterior opening of the rotated intervertebral discs, is a universal phenomenon
among idiopathic, non-idiopathic and compensatory scoliotic curves, that can occur
in the spine of any species. Therefore, scoliosis seems to be a universal rotational
(de)compensation to any cause of disturbance of spinal equilibrium, hence the title of
this thesis.
Scoliosis has a 20-fold increased prevalence in 22q11.2 deletion syndrome, this
thesis demonstrated that scoliosis in these children morphologically and dynamically
resembles idiopathic scoliosis, supporting the use of these patients as a ‘model’ to
prospectively study scoliosis in general. In this thesis this model provided prospective
evidence that the severity of the posteriorly inclined segment (part of any spine) is a risk
factor for scoliosis. While important clues in idiopathic scoliosis etiology have historically
been drawn from retrospective studies, this model enables prospective research, which
is the only way to truly confirm or discard these clues, distinguishing between cause
and effect of the disorder and contribute certainties to the ongoing effort of taking the
‘I’ out of AIS (Adolescent Idiopathic Scoliosis). Identifying causal factors that are already
present before scoliosis development may be used as biomarkers in identifying those
at risk in the general population. Screening and prevention currently have next to no
place in scoliosis clinical care, while this has been proven to be the most effective way
in battling any disease, especially on population level.
It is time to take the big leap, and transfer the focus from watchful waiting and treatment
of secondary symptoms, towards developing prevention that targets the primary
disease process.
show less